CNR2 and non-Hodgkin lymphoma: Non-Hodgkin lymphoma cells expressed higher mRNA levels of CB1 and/or CB2 receptors compared to reactive lymphoid tissue [23], and mantle cell lymphoma consistently overexpressed CB1 and CB2 in comparison to normal purified B lymphocytes and reactive lymphoid tissue [24].